The purpose of this study is to identify the links that exist between the disease phenotype (phenotype refers to observable signs and symptoms) and the disease genotype (genotype refers to your genetic information). We also want to identify biomarkers of ALS and related diseases.
Contact site for start date.
Please contact ClinicalResearch@sutterhealth.org about Study Phenotype, Genotype and Biomarker
View study details on ClinicalTrials.gov
Subjects with amyotrophic lateral sclerosis (ALS) also known as Lou Gehrig's disease and other related neurodegenerative diseases, including frontotemporal dementia (FTD), primary lateral sclerosis (PLS), hereditary spastic paraplegia (HSP), progressive muscular atrophy (PMA) and multisystem proteinopathy (MSP).
June 01, 2018